文献速递传染病防控与疫情报告卫生政策与健康促进

针对SARS-CoV-2的IgG抗体血清流行率——2020年3月至10月比利时基于残留样本的系列前瞻性横断面全国研究

Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020.
PubMed 文献 · Euro Surveill · 2022-01-01

该研究在2020年3月30日至10月17日间分七个时段对比利时门诊患者残留血清进行SARS-CoV-2 S1蛋白IgG抗体检测,按年龄、性别和地区分层并校正检测灵敏度和特异度。加权总体血清流行率从1.8%升至5.3%,封锁3周内血清发病率为3.4%,此后稳定,解封后部分时段比较出现显著下降;最后一时段(2020年10月中旬)加权总体血清流行率为4.2%。

要点

  • 加权总体血清流行率由1.8%(95%CrI:1.0-2.6)升至5.3%(95%CrI:4.2-6.4)。
  • 封锁3周内血清发病率为3.4%(95%CrI:2.4-4.6)。
  • 2020年10月中旬最后一时段加权总体血清流行率为4.2%(95%CrI:3.1-5.2)。

核心结论

  • 封锁期间比利时人口中 initially 一小部分但比例上升者出现SARS-CoV-2暴露的血清学可检测迹象,在限制措施放松和全面封锁解除后未进一步升高。

研究设计与样本

  • 系列前瞻性横断面全国研究,在2020年3月30日至10月17日的七个时段内使用3000至4000份残留样本,按年龄、性别和地区分层,以半定量商业ELISA检测门诊患者残留血清中针对SARS-CoV-2 S1蛋白的IgG抗体,并在估计中校正检测灵敏度和特异度。

主要发现

  • 加权总体血清流行率最初从1.8%(95%CrI:1.0-2.6)升至5.3%(95%CrI:4.2-6.4)。
  • 封锁期间第一与第二采集时段之间约3周内的血清发病率为3.4%(95%CrI:2.4-4.6)。
  • 此后血清流行率趋于稳定,但第三时段与第五、第六和第七时段比较时观察到显著下降,导致解除封锁后血清发病率估计为负值。
  • 最后采集时段(2020年10月中旬)的加权总体血清流行率为4.2%(95%CrI:3.1-5.2)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundTo control epidemic waves, it is important to know the susceptibility to SARS-CoV-2 and its evolution over time in relation to the control measures taken.AimTo assess the evolving SARS-CoV-2 seroprevalence and seroincidence related to the first national lockdown in Belgium, we performed a nationwide seroprevalence study, stratified by age, sex and region using 3,000-4,000 residual samples during seven periods between 30 March and 17 October 2020.MethodsWe analysed residual sera from ambulatory patients for IgG antibodies against the SARS-CoV-2 S1 protein with a semiquantitative commercial ELISA. Weighted seroprevalence (overall and by age category and sex) and seroincidence during seven consecutive periods were estimated for the Belgian population while accommodating test-specific sensitivity and specificity.ResultsThe weighted overall seroprevalence initially increased from 1.8% (95% credible interval (CrI): 1.0-2.6) to 5.3% (95% CrI: 4.2-6.4), implying a seroincidence of 3.4% (95% CrI: 2.4-4.6) between the first and second collection period over a period of 3 weeks during lockdown (start lockdown mid-March 2020). Thereafter, seroprevalence stabilised, however, significant decreases were observed when comparing the third with the fifth, sixth and seventh period, resulting in negative seroincidence estimates after lockdown was lifted. We estimated for the last collection period mid-October 2020 a weighted overall seroprevalence of 4.2% (95% CrI: 3.1-5.2).ConclusionDuring lockdown, an initially small but increasing fraction of the Belgian population showed serologically detectable signs of exposure to SARS-CoV-2, which did not further increase when confinement measures eased and full lockdown was lifted.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Herzog SA, De Bie J, Abrams S, et al. Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020. Euro Surveill. 2022. PMID: 35241216. doi:10.2807/1560-7917.ES.2022.27.9.2100419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。